US HB7828 | 2021-2022 | 117th Congress
Status
Spectrum: Strong Partisan Bill (Democrat 10-1)
Status: Introduced on May 18 2022 - 25% progression, died in committee
Action: 2022-05-18 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on May 18 2022 - 25% progression, died in committee
Action: 2022-05-18 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend the Public Health Service Act to shorten the exclusivity period for brand name biological products from 12 to 5 years.
Title
PRICED Act Price Relief, Innovation, and Competition for Essential Drugs Act
Sponsors
| Rep. Janice Schakowsky [D-IL] | Rep. Bruce Westerman [R-AR] | Rep. Ro Khanna [D-CA] | Rep. Lloyd Doggett [D-TX] |
| Rep. Mark Pocan [D-WI] | Rep. Marcy Kaptur [D-OH] | Rep. Jesus Garcia [D-IL] | Rep. Rosa DeLauro [D-CT] |
| Rep. Raja Krishnamoorthi [D-IL] | Rep. Andy Levin [D-MI] | Rep. Pramila Jayapal [D-WA] |
History
| Date | Chamber | Action |
|---|---|---|
| 2022-05-18 | House | Referred to the House Committee on Energy and Commerce. |
| 2022-05-18 | House | Introduced in House |
Same As/Similar To
SB1898 (Related) 2021-05-27 - Read twice and referred to the Committee on Finance.
HB8588 (Related) 2022-11-01 - Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
HB8588 (Related) 2022-11-01 - Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/117th-congress/house-bill/7828/all-info |
| Text | https://www.congress.gov/117/bills/hr7828/BILLS-117hr7828ih.pdf |
